1.Erratum: A Multicenter Retrospective Study on the Efficacy and Safety of Dupilumab in Elderly Korean Patients Aged 65 Years and Older with Chronic Pruritus
Yu Jin LEE ; Byeol HAN ; Chan Ho NA ; Jun Ho KWAK ; Min Kyung SHIN ; Jua LEE ; Ji Young AHN ; Hoeun GWAG ; Yong Hyun JANG ; Seung Soo LEE ; Tae Young HAN
Korean Journal of Dermatology 2026;64(1):46-46
2.A Multicenter Retrospective Study on the Efficacy and Safety of Dupilumab in Elderly Korean Patients Aged 65 Years and Older with Chronic Pruritus
Yu Jin LEE ; Byeol HAN ; Chan Ho NA ; Jun Ho KWAK ; Min Kyung SHIN ; Jua LEE ; Ji Young AHN ; Hoeun GWAG ; Yong Hyun JANG ; Seung Soo LEE ; Tae Young HAN
Korean Journal of Dermatology 2025;63(6):147-154
Background:
Recently, the prevalence of atopic dermatitis (AD) in the elderly has increased and has been reported to be as high as 4%, emphasizing its clinical significance. Treating pruritus in elderly patients can be challenging due to the high prevalence of comorbidities and adverse events associated with conventional systemic medications.Dupilumab has demonstrated favorable safety and effectiveness across all age groups, making it a promising treatment option for the elderly population.
Objective:
To evaluate the efficacy and safety of dupilumab in elderly patients with AD or other pruritic conditions.
Methods:
A multicenter, retrospective, real-world study on the efficacy and safety of dupilumab was conducted in patients aged 65 years or older. Patients with AD and other pruritic conditions were assessed separately for dupilumab efficacy using objective and subjective scores. The patients who received regular injections were evaluated at 16 and 40 weeks after treatment.
Results:
Forty-seven patients participated in the study, of whom 37 were diagnosed with AD and 10 were classified as having other pruritic conditions. In patients with AD, there was a 78.6% reduction in the mean Eczema Area and Severity Index score at week 16 compared with baseline. All patients with other pruritic conditions demonstrated a decrease in the Investigator’s Global Assessment score of at least 2 points or a Numerical Rating Score reduction of at least 4 points. Adverse events occurred in five patients, but no serious adverse reactions were observed.
Conclusion
Dupilumab can be considered a safe and effective treatment for elderly patients with AD and other pruritic conditions.
3.Optimization of Extraction Condition of Hesperidin in Citrus unshiu Peels using Response Surface Methodology.
Jua LEE ; Shinyoung PARK ; Ji Yeon JEONG ; Yang Hee JO ; Mi Kyeong LEE
Natural Product Sciences 2015;21(2):141-145
Hesperidin, which is the most abundant flavonoid of Citrus unshiu (Rutaceae), has been reported to possess diverse activities and widely used as functional foods and cosmetics. For the development of functional products, extraction procedure is indispensable. Extraction conditions affect the composition of extract as well as its biological activity. Therefore, we tried to optimize extraction conditions such as extraction solvent, extraction time and extraction temperature for maximum yield of hesperidin using response surface methodology with threelevel-three-factor Box-Behnken design (BBD). Regression analysis showed a good fit of the experimental data and the optimal condition was obtained as ethanol concentration, 59.0%; temperature 71.5degrees C and extraction time, 12.4 h. The hesperidin yield under the optimal condition was found to be 287.8 microg per 5 mg extract, which was well matched with the predicted value of 290.5 microg. These results provides optimized extraction condition for hesperidin and might be useful for the development of hesperidin as functional products like health supplements, cosmetics and medicinal products.
Citrus*
;
Ethanol
;
Functional Food
;
Hesperidin*
Result Analysis
Print
Save
E-mail